Drug Approval | March 21, 2022
Glenmark receives ANDA approval for Lacosamide tablets
The company plans to launch the product immediately
The company plans to launch the product immediately
The drug is indicated for use in combination with other drugs
Sputnik Light is the first component of Sputnik V
Opdualag is a first-in-class, fixed-dose dual immunotherapy combination treatment of the PD-1 inhibitor nivolumab and novel LAG-3-blocking antibody relatlimab
First and only FDA-approved treatment for seizures associated with CDKL5 deficiency disorder (CDD) in patients two years of age and older
Srichakra receives European Food Safety approval for its food-grade recycled rPET
Tapestri Platform powers Nature Cardiovascular Research publication that identifies two somatic mutations associated with sporadic brain blood vessel disorder
Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)
He was earlier associated with leading industry players like Hindustan Unilever, TATA Communications, Dr. Lal Path Labs, Oncquest and Metropolis Healthcare
It is only the second generic application approved by the USFDA
Subscribe To Our Newsletter & Stay Updated
